Matthew S. Miller

8.4k total citations · 1 hit paper
134 papers, 5.1k citations indexed

About

Matthew S. Miller is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Matthew S. Miller has authored 134 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 40 papers in Infectious Diseases and 37 papers in Molecular Biology. Recurrent topics in Matthew S. Miller's work include Influenza Virus Research Studies (39 papers), SARS-CoV-2 and COVID-19 Research (24 papers) and Respiratory viral infections research (23 papers). Matthew S. Miller is often cited by papers focused on Influenza Virus Research Studies (39 papers), SARS-CoV-2 and COVID-19 Research (24 papers) and Respiratory viral infections research (23 papers). Matthew S. Miller collaborates with scholars based in Canada, United States and Australia. Matthew S. Miller's co-authors include Thomas F. Burks, Peter Palese, Sam Afkhami, Zhou Xing, Brian D. Lichty, Mangalakumari Jeyanathan, Fiona Smaill, Caitlin E. Mullarkey, Florian Krammer and James J. Galligan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Matthew S. Miller

127 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunological considerations for COVID-19 vaccine strategies

2020 694 citations Mangalakumari Jeyanathan, Sam Afkhami et al. profile →

Peers

Countries citing papers authored by Matthew S. Miller

Since Specialization

Citations

This map shows the geographic impact of Matthew S. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Miller more than expected).

Fields of papers citing papers by Matthew S. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Miller. The network helps show where Matthew S. Miller may publish in the future.

Co-authorship network of co-authors of Matthew S. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Miller. A scholar is included among the top collaborators of Matthew S. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Miller. Matthew S. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Testicular Pain After Living Kidney Donation: Results From a Multicenter Cohort Study 2025 ·Canadian Journal of Kidney Health and Disease ·Amit X. Garg, Liane S. Feldman, Jessica M. Sontrop, Meaghan S. Cuerden, Jennifer Arnold, Neil Boudville, Martin Karpinski, Scott Klarenbach, Greg Knoll, Charmaine E. Lok, Eric McArthur, Matthew S. Miller, Mauricio Monroy‐Cuadros, Kyla L. Naylor, G. V. Ramesh Prasad, Leroy Storsley, Christopher Nguan	1
2	AeroVax: study protocol for a randomised, double-blind, placebo-controlled phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans 2025 ·ERJ Open Research ·Adam S. Komorowski, Lawrence Mbuagbaw, Mangalakumari Jeyanathan, Sam Afkhami, Marilyn Swinton, Michael R. D’Agostino, Karen Howie, Maria Fe C. Medina, Gail M. Gauvreau, (unknown), Imran Satia, Brian D. Lichty, Matthew S. Miller, D. William Cameron, Scott A. Halperin, Lehana Thabane, Mark Loeb, Zhou Xing, Fiona Smaill	0
3	LPS-induced lung tissue-resident trained innate immunity provides differential protection against pneumococci and SARS-CoV-2 2024 ·Cell Reports ·Alisha Kang, (unknown), Sam Afkhami, (unknown), Kanwaldeep Singh, Anna Dvorkin‐Gheva, Tobias Berg, Matthew S. Miller, Mangalakumari Jeyanathan, Zhou Xing	9
4	High‐Precision Viral Detection Using Electrochemical Kinetic Profiling of Aptamer‐Antigen Recognition in Clinical Samples and Machine Learning 2024 ·Angewandte Chemie International Edition ·Payel Sen, Zijie Zhang, (unknown), Jimmy Gu, (unknown), Bal Ram Adhikari, (unknown), (unknown), Jann C. Ang, (unknown), Bruno J. Salena, (unknown), Matthew S. Miller, Yingfu Li, Leyla Soleymani	22
5	Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study 2023 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), Rumi Clare, Ali Zhang, Jann C. Ang, Hannah D. Stacey, Limin Liu, (unknown), (unknown), (unknown), Tara Kajaks, Jonathan L. Bramson, Ishac Nazy, Matthew S. Miller, Andrew P. Costa, Dawn M. E. Bowdish, (unknown)	5
6	Does a Reduction in Receiving Assistance With Daily Activities Among Older Adults in Mexico Indicate An Increase in Unmet Needs or a Decrease in Needs for Care? 2023 ·The Journals of Gerontology Series B ·Brian Downer, Rafael Samper‐Ternent, (unknown), Matthew S. Miller, Rebeca Wong	1
7	Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis 2023 ·Scientific Reports ·(unknown), (unknown), Jann C. Ang, (unknown), Angela Huynh, (unknown), Barbara Baker, (unknown), (unknown), Elizabeth Yan, Joycelyne Ewusie, Ishac Nazy, Jonathan L. Bramson, Matthew S. Miller, Sasha Bernatsky, Maggie Larché, Dawn M. E. Bowdish, (unknown)	2
8	Self-assembled block copolymer biomaterials for oral delivery of protein therapeutics 2023 ·Biomaterials ·(unknown), Matthew S. Miller, (unknown), (unknown), Nicholas A. Peppas	16
9	Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination 2022 ·The Journal of Immunology ·(unknown), (unknown), Angela Huynh, Ali Zhang, (unknown), (unknown), Hannah D. Stacey, Jann C. Ang, Jonathan L. Bramson, Ishac Nazy, Matthew S. Miller, Judah A. Denburg, Andrew P. Costa, Dawn M. E. Bowdish	10
10	Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions 2022 ·Cell Reports Medicine ·Ali Zhang, (unknown), (unknown), Michael R. D’Agostino, Jann C. Ang, (unknown), Matthew S. Miller	10
11	IgA potentiates NETosis in response to viral infection 2021 ·Proceedings of the National Academy of Sciences ·Hannah D. Stacey, (unknown), (unknown), Jann C. Ang, (unknown), Muhammad Atif Zahoor, Charu Kaushic, Ewa Cairns, Dawn M. E. Bowdish, Caitlin E. Mullarkey, Matthew S. Miller	38
12	A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge 2021 ·Proceedings of the National Academy of Sciences ·(unknown), Xuedan He, Ali Zhang, Jann C. Ang, Shuai Shao, Amal Seffouh, Wei‐Chiao Huang, Michael R. D’Agostino, (unknown), Suryaprakash Sambhara, Joaquı́n Ortega, Hanné Andersen, Matthew S. Miller, Bruce A. Davidson, Jonathan F. Lovell	27
13	Potentiation of long-acting β2-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP 2021 ·Respiratory Research ·Yechan Kim, (unknown), Ryan D. Huff, Jennifer A. Aguiar, Spencer Revill, (unknown), Quynh Cao, Matthew S. Miller, Mark D. Inman, Kjetil Ask, Andrew C. Doxey, Jeremy A. Hirota	3
14	Engineered Nanoparticle Applications for Recombinant Influenza Vaccines 2020 ·Molecular Pharmaceutics ·(unknown), Matthew S. Miller, Jonathan F. Lovell	17
15	Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus 2020 ·Journal of General Virology ·Arinjay Banerjee, Andrew C. Doxey, Benjamin J.-M. Tremblay, Michael J. Mansfield, Sonu Subudhi, Jeremy A. Hirota, Matthew S. Miller, Andrew G. McArthur, Samira Mubareka, Karen Mossman	12
16	Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children 2019 ·Vaccines ·Jann C. Ang, Biao Wang, (unknown), (unknown), Florian Krammer, Brian J. Ward, Margaret L. Russell, Mark Loeb, Matthew S. Miller	8
17	Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959–2016 2019 ·Demography ·Enrique Acosta, (unknown), Lisa Dillon, Nadine Ouellette, Robert Bourbeau, D. Ann Herring, Kris Inwood, David J. D. Earn, Joaquı́n Madrenas, Matthew S. Miller, Alain Gagnon	11
18	Excipient selection for thermally stable enveloped and non-enveloped viral vaccine platforms in dry powders 2019 ·International Journal of Pharmaceutics ·(unknown), Sam Afkhami, (unknown), Cécile Fradin, Brian D. Lichty, Matthew S. Miller, Zhou Xing, Emily D. Cranston, Michael R. Thompson	28
19	Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice 2017 ·Nature Communications ·Wenqian He, Chi-Jene Chen, Caitlin E. Mullarkey, Jennifer Hamilton, Christine Wong, Paul E. Leon, Melissa B. Uccellini, Veronika Chromikova, Carole Henry, Kevin W. Hoffman, Jean K. Lim, Patrick C. Wilson, Matthew S. Miller, Florian Krammer, Peter Palese, Gene S. Tan	125
20	Peering into the Crystal Ball: Influenza Pandemics and Vaccine Efficacy 2014 ·Cell ·Matthew S. Miller, Peter Palese	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact